Moleculin Biotech
(NASDAQ) MBRX
Moleculin Biotech Financials at a Glance
Market Cap
$10.16M
Revenue (TTM)
$0.00
Net Income (TTM)
$33.56M
EPS (TTM)
$-41.71
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$2.06
Volume
0
Open
$2.07
Price
$2.06
Volume
0
Open
$2.07
Previous Close
$2.06
Daily Range
$2.00 - $2.07
52-Week Range
$1.79 - $33.00
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$2.06
Volume
0
Open
$2.07
Previous Close
$2.06
Daily Range
$2.00 - $2.07
52-Week Range
$1.79 - $33.00
MBRX News
MBRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Moleculin Biotech
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
Walter V. Klemp, CPA
Website
www.moleculin.comHeadquarters
Houston, TX 77007, US
MBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-228%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
-0.31%
Stock Overview
Market Cap
$10.16M
Shares Outstanding
4.93M
Volume
0
Short Interest
0.00%
Avg. Volume
180.59K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$25.10M
EBITDA
$25.01M
Operating Cash Flow
$22.73M
Capital Expenditure
$0.00
Free Cash Flow
$22.73M
Cash & ST Invst.
$8.88M
Total Debt
$222.00K
Moleculin Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$10.16M
N/A
Market Cap/Employee
$597.78K
N/A
Employees
17
N/A
Net Income
$5.92M
+414.3%
EBITDA
$7.43M
-301.6%
Quarterly Fundamentals
Net Cash
$8.66M
+127.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$222.00K
-38.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.52%
N/A
Return on Invested Capital
-1.64%
N/A
Free Cash Flow
$5.37M
-5.6%
Operating Cash Flow
$5.37M
-5.6%